Clariant : Q2 EBITDA in line, higher margin guidance also in line. On track.
>Organic sales down 3% solely on pricing (pass-through) - Organic sales down by 3% y-o-y fuelled by flat volumes in Q2 2024 (Q1 24: -1%) and -3% y-o-y in prices (Q1 2024: -5%) mainly via pass-throughs as well as 0% forex pushed sales down 3%y-o-y to CHF 1,056m (cons./ODDO BHF CHF 1,036m/CHF 1,030m). Q2 EBITDA CHF 166m in line with cons. of CHF 164m (ODDO BHF CHF 1 60m) - Q2 EBITDA was CHF 166m, 1% above the consensus forecast for CHF 164m (ODDO BHF ...Clariant is a specialty chemicals group based in Switzerland. Co. develops, manufactures, distributes and sells a broad range of specialty chemicals which play a key role in its customers' manufacturing and treatment processes or add value to their end products. Co. has manufacturing plants around the world and sells mainly in countries within Europe, the Americas and Asia. Co.'s businesses are organized into four business areas: Care Chemicals (BU Industrial & Consumer Specialties), Catalysis & Energy (BU Catalysts, Business Line Energy Storage), Natural Resources (BU Oil & Mining Services, BU Functional Minerals), and Plastics & Coatings (BU Additives, BU Masterbatches, BU Pigments).
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.